| Cellular and molecular profiling of tumor microenvironment and early-stage lung cancer R Pirlog, P Chiroi, I Rusu, AM Jurj, L Budisan, C Pop-Bica, C Braicu, ... International journal of molecular sciences 23 (10), 5346, 2022 | 21 | 2022 |
| Cancer-associated stemness and epithelial-to-mesenchymal transition signatures related to breast invasive carcinoma prognostic IM Groza, C Braicu, A Jurj, O Zanoaga, R Lajos, P Chiroi, R Cojocneanu, ... Cancers 12 (10), 3053, 2020 | 21 | 2020 |
| The role of miR-155 in nutrition: modulating cancer-associated inflammation O Zanoaga, C Braicu, P Chiroi, N Andreea, NA Hajjar, S Mărgărit, ... Nutrients 13 (7), 2245, 2021 | 15 | 2021 |
| Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in oral squamous cell carcinoma: a potential biomarkers panel? O Aghiorghiesei, O Zanoaga, L Raduly, AI Aghiorghiesei, P Chiroi, A Trif, ... Current issues in molecular biology 44 (4), 1754-1767, 2022 | 10 | 2022 |
| The implications of noncoding rnas in the evolution and progression of nonalcoholic fatty liver disease (Nafld)-related hcc I Rusu, R Pirlog, P Chiroi, A Nutu, VR Puia, AC Fetti, DR Rusu, ... International Journal of Molecular Sciences 23 (20), 12370, 2022 | 9 | 2022 |
| Comprehensive analysis of the expression of key genes related to hippo signaling and their prognosis impact in ovarian cancer P Kubelac, C Braicu, L Raduly, P Chiroi, A Nutu, R Cojocneanu, ... Diagnostics 11 (2), 344, 2021 | 8 | 2021 |
| Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms E Isacescu, P Chiroi, O Zanoaga, A Nutu, L Budisan, R Pirlog, ... Antioxidants 12 (2), 407, 2023 | 4 | 2023 |
| New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs BO Pirlog, S Ilut, R Pirlog, P Chiroi, A Nutu, DI Radutiu, GD Cuc, ... Expert Reviews in Molecular Medicine 25, e18, 2023 | 4 | 2023 |
| C,O‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity AA Someșan, SM Vieriu, A Crăciun, C Silvestru, P Chiroi, A Nutu, A Jurj, ... Applied Organometallic Chemistry 36 (3), e6540, 2022 | 3 | 2022 |
| Microarrays and NGS for drug discovery LA Pop, O Zanoaga, P Chiroi, A Nutu, SS Korban, C Stefan, A Irimie, ... Drug Design-Novel Advances in the Omics Field and Applications, 2021 | 3 | 2021 |
| Vinorelbine Alters lncRNA Expression in Association with EGFR Mutational Status and Potentiates Tumor Progression Depending on NSCLC Cell Lines’ Genetic Profile H Alsharoh, P Chiroi, A Nutu, L Raduly, O Zanoaga, I Berindan-Neagoe Biomedicines 11 (12), 3298, 2023 | 2 | 2023 |
| Identification of a miRNA panel with a potential determinant role in patients suffering from periodontitis O Baru, L Raduly, C Bica, P Chiroi, L Budisan, N Mehterov, C Ciocan, ... Current issues in molecular biology 45 (3), 2248-2265, 2023 | 2 | 2023 |
| Profiling canine mammary tumors: A potential model for studying human breast cancer LM Gherman, P Chiroi, A Nuţu, C Bica, I Berindan-Neagoe The Veterinary Journal, 106055, 2023 | 1 | 2023 |
| Non-Coding RNAs and Reactive Oxygen Species–Symmetric Players of the Pathogenesis Associated with Bacterial and Viral Infections Z Milhem, P Chiroi, A Nutu, M Ilea, M Lupse, O Zanoaga, ... Symmetry 13 (7), 1307, 2021 | 1 | 2021 |
| Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer H Alsharoh, P Chiroi, E Isachesku, RA Tanasa, OL Pop, R Pirlog, ... Biomedicines 12 (7), 1489, 2024 | | 2024 |
| Distinct Morphological and Molecular Profiles of NAFLD and NAFLD-associated HCC Revealed by Immunohistochemistry and MicroRNA Analysis. I Rusu, R Pirlog, P Chiroi, A Nutu, L Budisan, VR Puia, C Braicu, ... Journal of Gastrointestinal & Liver Diseases 32 (3), 2023 | | 2023 |
| Alteration of the miR-21, miR-155 and miR-181a expression level in breast cancer: implications in the immune response and possible prognostic value. P Chiroi, E Isăcescu, M Groza, C Ciocan, C Bica, OL Pop, C Braicu, ... Oncolog-Hematolog, 2023 | | 2023 |
| Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts? R Pirlog, P Chiroi, L Raduly, A Nutu, A Cismaru, I Berindan-Neagoe | | 2023 |
| Tumor Microenvironment Characterization as a Source of Novel Molecular Biomarkers in Early-stage Lung Cancer R Pirlog, I Rus, P Chiroi, A Jurj, L Budisan, I Neagoe, D Crisan, ... LABORATORY INVESTIGATION 102 (SUPPL 1), 1336-1338, 2022 | | 2022 |
